We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-6.99%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.71B
AUM Growth
-$39.6M
Cap. Flow
+$72.3M
Cap. Flow %
4.23%
Top 10 Hldgs %
57.63%
Holding
146
New
23
Increased
28
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$28.5M
2
ESTA icon
Establishment Labs
ESTA
+$27.8M
3
PTON icon
Peloton Interactive
PTON
+$16.6M
4
SVRA icon
Savara
SVRA
+$15.3M
5
OPTN
OptiNose
OPTN
+$12.2M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$25.3M
2
LYRA
LYRA THERAPEUTICS INC
LYRA
+$17.5M
3
RDVT icon
Red Violet
RDVT
+$13.4M
4
DYN icon
Dyne Therapeutics
DYN
+$12.4M
5
GDEN
Golden Entertainment
GDEN
+$9.92M

Sector Composition

Rank Sector Weight
1 Healthcare 39.62%
2 Consumer Discretionary 7%
3 Financials 3.63%
4 Communication Services 3.53%
5 Technology 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSVR
26
Reservoir Media
RSVR
$667M
$12.3M 0.72%
1,550,797
– –
QURE icon
27
uniQure
QURE
$3.22B
$11.9M 0.69%
2,650,472
-437,610
-14% -$2.13M
ZVRA icon
28
Zevra Therapeutics
ZVRA
$686M
$11.9M 0.69%
2,419,435
-33,970
-1% -$161K
PAYO icon
29
Payoneer
PAYO
$2.41B
$11.7M 0.69%
2,115,653
+294,227
+16% +$1.59M
ASRT
30
DELISTED
Assertio
ASRT
$11.5M 0.67%
618,056
– –
TELA icon
31
TELA Bio
TELA
$38.9M
$11.5M 0.67%
2,445,667
+1,347,801
+123% +$7.1M
RDVT icon
32
Red Violet
RDVT
$924M
$11.5M 0.67%
452,457
-663,792
-59% -$13.4M
CDXS icon
33
Codexis
CDXS
$158M
$11.3M 0.66%
3,629,622
-832,256
-19% -$2.67M
EGRX
34
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$11M 0.64%
1,962,070
+703,308
+56% +$3.06M
AURA icon
35
Aura Biosciences
AURA
$826M
$9.6M 0.56%
1,270,035
-51,825
-4% -$380K
VMD icon
36
Viemed Healthcare
VMD
$371M
$9.4M 0.55%
1,435,122
-115,000
-7% -$867K
SNDX icon
37
Syndax Pharmaceuticals
SNDX
$1.82B
$9.3M 0.54%
453,232
-12,027
-3% -$252K
IMTX icon
38
Immatics
IMTX
$1.32B
$9.16M 0.54%
787,974
– –
TRML
39
DELISTED
Tourmaline Bio
TRML
$9.01M 0.53%
700,907
– –
VNDA icon
40
Vanda Pharmaceuticals
VNDA
$302M
$9M 0.53%
1,593,516
+580,265
+57% +$3M
ELUT icon
41
Elutia
ELUT
$37.6M
$8.91M 0.52%
1,795,697
+145,697
+9% +$473K
EHTH icon
42
eHealth
EHTH
$43.9M
$8.66M 0.51%
1,911,821
– –
HLF icon
43
CALL
Herbalife
HLF
$1.29B
$8.31M 0.49%
800,000
+300,000
+60% +$3M
EB
44
DELISTED
Eventbrite
EB
$7.74M 0.45%
+1,600,000
New +$8.35M
LXFR icon
45
Luxfer Holdings
LXFR
$458M
$7M 0.41%
604,143
-81,110
-12% -$901K
ILPT
46
Industrial Logistics Properties Trust
ILPT
$586M
$6.88M 0.4%
1,869,953
-11,179
-0.6% -$43.2K
OCUL icon
47
Ocular Therapeutix
OCUL
$2.02B
$6.84M 0.4%
+1,000,000
New +$6.17M
NDLS icon
48
Noodles & Co
NDLS
$107M
$6.81M 0.4%
538,541
+34,375
+7% +$490K
RMR icon
49
The RMR Group
RMR
$332M
$6.8M 0.4%
300,792
-45,000
-13% -$1.05M
ENVA icon
50
CALL
Enova International
ENVA
$6.29B
$6.79M 0.4%
109,000
– –
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Nantahala Capital Management held 146 positions worth $1.71B, down 2.3% from $1.75B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Nantahala Capital Management deployed $72.3M of net new capital in Q2 2024, opening 23 new positions and adding to 28 existing holdings. Its largest new stake was The Bancorp: 337,846 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Pathward Financial, an estimated $25.3M trimmed.

  • Nantahala Capital Management's largest Q2 2024 buy was The Bancorp: 337,846 shares worth $12.8M.
  • Nantahala Capital Management added most to Soleno Therapeutics in Q2 2024, an estimated $28.5M increase.
  • Nantahala Capital Management's biggest Q2 2024 reduction was Pathward Financial, cutting an estimated $25.3M.
  • Nantahala Capital Management fully exited LYRA THERAPEUTICS INC in Q2 2024, selling an estimated $17.5M.
  • Nantahala Capital Management's ten largest holdings make up 58% of its $1.71B portfolio in Q2 2024.
  • Nantahala Capital Management opened 23 new positions and closed 16 in Q2 2024.
  • Nantahala Capital Management's portfolio value fell 2.3% quarter-over-quarter to $1.71B.

Based on Nantahala Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.